We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Avacta Sign Third Distribution Agreement with Pall Life Sciences
News

Avacta Sign Third Distribution Agreement with Pall Life Sciences

Avacta Sign Third Distribution Agreement with Pall Life Sciences
News

Avacta Sign Third Distribution Agreement with Pall Life Sciences

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Avacta Sign Third Distribution Agreement with Pall Life Sciences"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Avacta Analytical has signed a third distribution agreement with Pall Life Sciences - appointing Pall as the Indian distributor for its market-leading Optim 1000 protein drug development tool.

The Optim 1000 is an innovative analytical instrument that provides biopharmaceutical developers with information about the viability of candidate drug molecules and formulations much earlier in the drug development process, avoiding costly end stage product failures.

The latest collaboration extends the existing North America and South East Asia agreements, granting Pall exclusive marketing and distribution rights to the Optim 1000, to include India.

Alastair Smith, Chief Executive of Avacta Group, commented: “Pall has proved an excellent partner for Avacta, and the success of our existing collaborations in North America and South East Asia was a major factor in the decision to appoint the Company as the sole distributor for the Optim 1000 in India. The Indian biopharma industry is growing rapidly, offering exciting new opportunities, and we look forward to working with Pall in this new territory.”

Advertisement